PlainRecalls
FDA Drug Moderate Class II Terminated

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

Reported: March 10, 2021 Initiated: February 15, 2021 #D-0297-2021

Product Description

Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray)

Reason for Recall

Chemical contamination; Unknown brown residue adhering to the inside of one vial.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
9,452 cartons
Distribution
Nationwide, including Puerto Rico
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Metoclopramide Injection USP, 10 mg/2 mL (5 mg/mL), 25x2mL Single Dose Vials, Rx only, Distributed by Teva Pharmaceuticals, USA, Inc., Parsippany, NJ Vial NDC 0703-4502-01 (vial) NDC# 0703-4502-04 (tray). Recalled by Teva Pharmaceuticals USA. Units affected: 9,452 cartons.
Why was this product recalled?
Chemical contamination; Unknown brown residue adhering to the inside of one vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 10, 2021. Severity: Moderate. Recall number: D-0297-2021.